Management of Blood Pressure in Brain Stem Stroke

Acute Phase Management

The American Heart Association recommends that blood pressure should generally not be treated during the acute phase unless it exceeds 220/120 mmHg, with the goal of maintaining optimal cerebral perfusion 3, 4
If blood pressure exceeds 220/120 mmHg, the American College of Cardiology suggests reducing mean arterial pressure by only 15% over 24 hours—not more aggressively, to avoid compromising cerebral perfusion 1, 5
In patients receiving IV thrombolysis, the American Heart Association recommends that blood pressure must be lowered to <185/110 mmHg before treatment and maintained <180/105 mmHg for 24 hours afterward to prevent hemorrhagic transformation, with a strength of evidence classified as Class I, Level A 4, 2, 5

The American College of Cardiology recommends initiating or restarting antihypertensive therapy once the patient is neurologically stable, typically after 3 days, if blood pressure remains ≥140/90 mmHg, with a target blood pressure of <130/80 mmHg 1, 2, 5
The American Heart Association suggests that an ACE inhibitor combined with a thiazide diuretic is the evidence-based combination for long-term secondary prevention, with Class I, Level A evidence, reducing recurrent stroke risk by 43% based on the landmark PROGRESS trial 1, 7, 2
Alternative acceptable agents for long-term secondary prevention include angiotensin II receptor blockers combined with thiazide diuretics, calcium channel blockers, and thiazide diuretics alone, according to the American College of Cardiology 1, 7, 8

The American Heart Association advises against aggressively lowering blood pressure in the first 48-72 hours unless it exceeds 220/120 mmHg or the patient is receiving reperfusion therapy, as this can extend infarct size by reducing perfusion to the penumbra, with a strength of evidence classified as Class IIa, Level B 3, 5
The American College of Cardiology recommends avoiding agents that cause precipitous blood pressure drops, such as sublingual nifedipine and sodium nitroprusside, as rapid reduction can compromise cerebral perfusion, with a strength of evidence classified as Class III, Level C 3, 5

The American Heart Association notes that brain stem strokes may cause cardiac arrhythmias or marked blood pressure changes due to autonomic dysfunction, requiring close monitoring and individualized management, with a strength of evidence classified as Class IIb, Level C 6
Hypotension is rare but associated with poor outcomes when present, and the American College of Cardiology suggests investigating for aortic dissection, volume depletion, or cardiac causes if it occurs, with a strength of evidence classified as Class IIa, Level B 3, 6

The American Heart Association recommends monitoring blood pressure every 15 minutes for 2 hours, every 30 minutes for 6 hours, then hourly for 16 hours if receiving thrombolysis during the acute phase, with a strength of evidence classified as Class I, Level A 5
For long-term management, the American College of Cardiology suggests measuring blood pressure at every routine visit and requiring monthly monitoring until target is achieved, with a strength of evidence classified as Class IIa, Level B 2, 8